Raymond Taeyong Chung, M.D.
This page shows the publications co-authored by Raymond Chung and Ruslan Sadreyev.
Type I, II, and III interferon signatures correspond to COVID-19 disease severity. J Infect Dis. 2021 May 24.
Type I, II, and III interferon signatures correspond to COVID-19 disease severity. medRxiv. 2021 Mar 12.
HELZ2 Is an IFN Effector Mediating Suppression of Dengue Virus. Front Microbiol. 2017; 8:240.
Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity. J Infect Dis. 2021 09 01; 224(5):777-782.
Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease. Clin Infect Dis. 2021 08 16; 73(4):621-630.
A MicroRNA Linking Human Positive Selection and Metabolic Disorders. Cell. 2020 10 29; 183(3):684-701.e14.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.